Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


European Medicines Agency or EMA, on Wednesday, recommended that a booster dose of Covid-19 Vaccine Janssen, developed by Janssen Pharmaceuticals, an arm of Johnson & Johnson (JNJ), may be considered at least 60 days after the first dose in individuals aged 18 years and above.


RTTNews | Dec 15, 2021 06:53AM EST

06:53 Wednesday, December 15, 2021 (RTTNews.com) - European Medicines Agency or EMA, on Wednesday, recommended that a booster dose of Covid-19 Vaccine Janssen, developed by Janssen Pharmaceuticals, an arm of Johnson & Johnson (JNJ), may be considered at least 60 days after the first dose in individuals aged 18 years and above.

EMA's move follows the latest figures which showed a rise in the presence of antibodies against SARS-CoV-2 in adults who have received a booster dose of Covid-19 Vaccine Janssen shot at least eight-week period after the first dose.

However, the risk of thrombosis in combination with thrombocytopenia (TTS) or other very rare side effects after a booster is not known and is being carefully monitored, EMA said in a statement. The agency also added that a booster dose with Covid-19 Vaccine Janssen may be given after two doses of one of the mRNA vaccines authorized in the EU- Comirnaty from Pfizer/BioNTech or Spikevax from Moderna.

Read the original article on RTTNews ( https://www.rttnews.com/3249445/ema-recommends-covid-19-vaccine-janssen-booster-shot-for-adults.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC